XML 85 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
Total
Common Stock
Preferred Stock
Stockholders' Equity (Deficit)
Stockholders' Equity (Deficit)
Common Stock
Stockholders' Equity (Deficit)
Preferred Stock
Common Stock
Common Stock
Common Stock
Preferred Stock
Preferred Stock
Preferred Stock
Additional Paid in Capital
Retained Earnings (Accumulated Deficit)
Non-Controlling Interest
Beginning balance, shares (in shares) at Dec. 31, 2020             281,827            
Beginning balance, shares (in shares) at Dec. 31, 2020                 0        
Beginning balance, value at Dec. 31, 2020 $ 6,414,700     $ 7,704,600     $ 11,956,900   $ 0   $ 234,800 $ (4,487,100) $ (1,289,900)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net proceeds from issuance of stock (in shares)               460,000   4,020,555      
Net proceeds from issuance of stock   $ 25,101,000 $ 66,572,300   $ 25,101,000 $ 66,572,300   $ 25,101,000   $ 66,572,300      
Exercise of stock options (in shares) 2,252           2,252            
Exercise of stock options $ 18,000     18,000             18,000    
Stock Compensation Expense (in shares)             3,025            
Stock Compensation Expense 499,900     499,900             499,900    
Preferred Stock Dividends (2,724,900)     (2,724,900)               (2,724,900)  
Repurchase of Stock (in shares)   (90,337)         (90,337)            
Repurchase of Stock (5,000,000) $ (5,000,000)   (5,000,000)     $ (5,000,000)            
Conversion of Preferred stock (in shares)             1,000   (3,600)        
Conversion of Preferred stock 0     0     $ 64,800   $ (64,800)        
Net Income (Loss) $ 8,856,800     8,858,500               8,858,500 (1,700)
Ending balance, shares (in shares) at Dec. 31, 2021 657,767           657,767            
Ending balance, shares (in shares) at Dec. 31, 2021 4,016,955               4,016,955        
Ending balance, value at Dec. 31, 2021 $ 99,737,800     101,029,400     $ 32,122,700   $ 66,507,500   752,700 1,646,500 (1,291,600)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Exercise of stock options (in shares) 1,081           1,081            
Exercise of stock options $ 8,600     8,600     $ 10,500       (1,900)    
Stock Compensation Expense (in shares)             5,293            
Stock Compensation Expense 515,500     515,500             515,500    
Dissolution of Non-Controlling Interest 0     (1,292,100)               (1,292,100) 1,292,100
Preferred Stock Dividends (7,759,900)     (7,759,900)               (7,759,900)  
Repurchase of Stock (in shares)   (12,597)         (12,597)            
Repurchase of Stock (437,700) $ (400,000)   (437,700)     $ (437,700)            
Conversion of Preferred stock (in shares)             60,326   (217,156)        
Conversion of Preferred stock 0     0     $ 3,595,400   $ (3,595,400)        
Exercise of Warrants (in shares)             6,965            
Exercise of Warrants 413,800     413,800     $ 413,800            
Net Income (Loss) $ (16,922,200)     (16,921,700)               (16,921,700) (500)
Ending balance, shares (in shares) at Dec. 31, 2022 718,835           718,835            
Ending balance, shares (in shares) at Dec. 31, 2022 3,799,799               3,799,799        
Ending balance, value at Dec. 31, 2022 $ 75,555,900     $ 75,555,900     $ 35,704,700   $ 62,912,100   $ 1,266,300 $ (24,327,200) $ 0